HESTER BIOSCIENCES
Back to Balance Sheet
|
HESTER BIOSCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹152 Cr | ₹125 Cr | ₹105 Cr | ₹149 Cr | ₹97 Cr |
What is the latest Total Current Liabilities ratio of HESTER BIOSCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹152 Cr |
| Mar2025 | ₹125 Cr |
| Mar2024 | ₹105 Cr |
| Mar2023 | ₹149 Cr |
| Mar2022 | ₹97 Cr |
How is Total Current Liabilities of HESTER BIOSCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹152 Cr | 21.80 | |
| Mar2025 | ₹125 Cr | 18.69 | |
| Mar2024 | ₹105 Cr | -29.07 | |
| Mar2023 | ₹149 Cr | 53.46 | |
| Mar2022 | ₹97 Cr | - | |
Compare Total Current Liabilities of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹1,813.7 Cr | 4.3% | 13.5% | 12.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,104.0 Cr | 3.5% | -1.5% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,119.0 Cr | 1.1% | -1.1% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,871.0 Cr | -0.2% | -0.3% | 35% | Stock Analytics | |
| CIPLA | ₹114,334.0 Cr | 3.1% | 1% | -11.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,761.0 Cr | 1.1% | -2.1% | -5.6% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | 4.3% |
13.5% |
12.5% |
| SENSEX | 1.1% |
2.4% |
-5% |
You may also like the below Video Courses